Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 5CNS 4Other hematologic neoplasm 3Gynecologic 3Sarcoma 2Breast 2Thoracic 1Plasma cell 1Myeloid 1Dermatologic 1

Conditions

Endometrial Neoplasms 8Ovarian Neoplasms 7Fallopian Tube Neoplasms 4Recurrence 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Neoplasms 2Breast Neoplasms 2Phase IB 1Multiple Myeloma 1Lung Neoplasms 1Endometrial Hyperplasia 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Gemcitabine 7Cyclophosphamide 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recurrence × Everolimus × Gynecologic × Clear all
NCT01068249 2026-04-30

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
42 enrolled 11 charts
Gynecologic

Recurrence, Endometrial Neoplasms

NCT01031381 2016-08-30

RADBEV

University of Pittsburgh

Phase 2 Completed
50 enrolled 7 charts
Gynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Recurrence

NCT02188550 2015-05-19

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Sinai Hospital of Baltimore

Phase 2 Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡